Welcome! Get 20% off this summer for our immunoassay and flow cytometry services.
This progress of immunology holds great promise for the development of new treatments for cancer, autoimmune, and infectious disease. Immuno-oncology is one of most exciting new development and has a tremendous potential to harness our powerful immune system to target and destroy cancer cells with few side effects. Researchers are exploring the complex relationship between tumor and the immune system within the tumor microenvironment in order to discover new immuno-oncology targets and therapies. A deep understanding of these targets is the key to unlocking the next blockbuster immunotherapy, kickstarting our immunity to fight cancer. Today’s in vitro models are more complex, requiring optimization, monitoring, and phenotypic characterization of cellular subpopulations Our Immunology solutions span the entire drug discovery workflow, from drug screening, pre-clinical efficacy, to evaluation of human immune cell activity from clinical trials. Our immune cell function assays, along with our immunoassays, are the perfect fit for these researches and developments, providing a broad range of highly reproducible, sensitive solutions for high-throughput screening, biomarker validation and efficacy studies.
T cell activation assay